Solenic Medical, an Addison, TX-based developer of a device that uses alternating magnetic fields (AMF) to treat a prosthetic joint infections (PJI), raised $5.1M in Series A funding.
The round was led by Johnson & Johnson Innovation – JJDC, Inc., joined by other major medical device investors such as ShangBay Capital and Highpoint Ventures.
The company intends to use the funds to expand operations and its R&D sector.
Led by James Y. Lancaster, CEO, Solenic Medical is a medical device company that works to develop and commercialize a method for treating prosthetic joint infections (PJI). It leverages properties of alternating magnetic fields (AMF) generated from external coils to eradicate biofilm on the surface of medical implants. Initially targeting the metallic components of knee implants, this product is the first in the company’s pipeline of treatments for most metallic medical implants including knees, hips, elbows, trauma devices and more.
FinSMEs
20/06/2023